IRVINE, Calif.--(BUSINESS WIRE)--Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Boston Scientific Corporation (“Boston Scientific” or the “Company”) (NYSE: BSX) concerning possible violations of federal securities laws.
If you purchased shares of Boston Scientific, and want more information free of charge, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at email@example.com.
On February 23, 2017, Boston Scientific announced it would be recalling its range of Lotus Valve heart devices, due to reports of an early release of a pin that connects the heart valve device to the delivery system.
Boston Scientific claims the problem is created by "excess tension in the pin mechanism introduced during the manufacturing process." When this information was released to the investing public, shares of Boston Scientific fell, causing investors harm.
If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at firstname.lastname@example.org.
This press release may constitute Attorney Advertising in some jurisdictions.